Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type

Pathology Research and Practice

Volumn 198, Issue 12, 2002, Pages 785-794

  Tsujimoto, Hiroyuki ^a,b   Hagiwara, Akeo ^b   Sugihara, Hiroyuki ^a   Hattori, Takanori ^a   Yamagishi, Hisakazu ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Gastric cancer; Methylation; p14ARF; p16INK4a

Indexed keywords

DNA; PROTEIN P14; PROTEIN P16; PROTEIN P53; MICROSATELLITE DNA; PRIMER DNA; PROTEIN P14ARF; PROTEIN P16INK4A;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; EARLY CANCER; FEMALE; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; MALE; MICROSATELLITE INSTABILITY; PLOIDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; CELL CULTURE; COMPARATIVE STUDY; CPG ISLAND; DNA METHYLATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; STOMACH TUMOR;

CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA PRIMERS; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; NEOPLASM METASTASIS; PLOIDIES; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036997091     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00337     Document Type: Article

References (43)

1. Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JH, Hamilton SR, Baylin SB, Issa JP (1997) Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57: 3370-3374
2. Barranco SC, Townsend CM, Cacilda Casartelli BG, Macik NL, Burger WR, Boerwinkle WR, Gourley WK (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43: 1703-1709
3. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
4. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van der Riet P, Blauground JE, Sidransky D (1994) Rates of p 16(MTS1) mutations in primary tumors with 9p loss. Science 265: 415-416
5. INK4a methylation and p53 mutation status. Cancer Res 60: 129-133
6. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229
7. ARF, and CDK4 in familial melanoma: analysis of a clinic-based population, Proc Natl Acad Sci (Wash) 93: 8541-8545
8. Fuchs CS, and Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333: 32-41
9. Hattori T, Hosakawa Y, Fukuda M, Sugihara H, Hamada S, Takamatsu T, Nakanishi K, Tsuchihashi Y, Kitamura T, Fujita S (1984) Analysis of DNA ploidy pattern of gastric carcinomas of Japanease. Cancer 54: 1591-1597
10. Hayashi K, Metzger R, Salonga D, Danenberg K, Leichman LP, Fink U, Sendler A, Kelsen D, Schwartz GK, Groshen S, Lenz H, Janenberg PV (1997) High frequency stimultaneous loss of p16- and p16beta-gene expression in squamous-cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene 15: 1481-1488
11. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB (1995) Inactivation of the CDK2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
12. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
13. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Wilson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB (1998) Incidence and functional consequence of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95: 6870-6875
14. Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T, Terada M (1994) Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. Biochem Biophys Res Commun 203: 1090-1095
15. Igaki H, Sasaki H, Tachimori Y, Kato H, Watanabe H, Kimura T, Harada Y, Sugimura T, Terada M (1995) Mutation frequency of the p16/CDKN2 gene in primary gastric cancers in upper digestive tract. Cancer Res 55: 3421-3423
16. ARF gene in gastric cancer. Int J Cancer 87: 654-658
17. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigan SV, Stockert E, Day III RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
18. ARF. Cell 91: 649-659
19. Kim H, Jen J, Vogelstein B, Hamilton SR (1994) Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 145: 148-156
20. INK4a: a gene with dual capacity to encode unrelated proteins that inhibit cell cycle progression. Oncogene 12: 2041-2044
21. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta pathol Microbial Scand 64: 31-49
22. Liggett WH, Jr Sewll DA, Rocco J, Ahrendt SA, Koch W, Sidransky D (1996) p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 67: 4119-4123
23. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom Lathi M, Pylkkane L, Heimdal K, Andersen TI, Moller P, Rognum TO, Fossa SD, Haidorsen T, Langmark F, Brogger A, de la Chapelle A, Borresen AL (1993) Genomic instability in colorectal cancer: relationship to clinicopathologic variables and family history. Cancer Res 53, 5849-5852
24. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M, Satodate R (1995) The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence dose not occur between gastric adenoma and adenocarcinoma. J Pathol 176: 249-258
25. Markl IDC, Jones PA (1998) Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res 58: 5348-5353
26. Merlo A, Herman JG, Mao L, Lee DJ, Gamrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5′ CpG-island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692
27. Moritani S, Sugihara H, Kushima R., Hattori T (2002) Different roles of p53 between Epstein-Barr Virus-positive and -negative gastric carcinomas of matched histology. Virchow Arch 440: 367-375
28. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000
29. Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J, Sidransky D (1999) Inactivation of the INK4A/ARF locus frequency coexists with TP53 mutations in non-small cell lung cancer. Oncogene 18: 5843-5849
30. Sharpless NE, DePinho RA (1999) The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 9: 22-30
31. Serrano M, Hannon GJ, Beach D (19939) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.) 366: 704-707
32. Sherr CJ (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev 12: 2434-2442
33. Shim YH, Kang GH, Ro JY (2000) Correlation of p 16 hypermethylation with the p16 protein loss in sporadic gastric carcinomas. Lab Invest 80: 689-695
34. Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, Kim WH, Bang YJ (2000) Methylation of specific CpG sites in the promoter region could significantly down-regulate p16 INK4a expression in gastric adenocacinoma. Int J Cancer 87: 236-240
35. Stones S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A (1995) Complex structure and regulation of the p16 (MTS1) locus. Cancer Res 55: 2988-2994
36. Sugihara H, Hattori T, Fukuda M, Katsura K, Fujita S (1993) Progression of signet ring cell carcinomas in the human stomach. Cancer 71: 1938-1947
37. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y, Imai K (1999) Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313
38. Toyota M, Ahuja N, Suzuki H, Itoh F, Toyota MO, Imai K, Baylin SB, Issa JJ (1999) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59: 5442-6438
39. Tsujimoto H, Sugihara H, Hagiwara A, Hattori T (1997) Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer. Virchow Arch 431: 383-389
40. Tsujimoto H, Sugihara H, Hagiwara A, Hattori T (1997) Microsatellite instability, DNA ploidy, and mutation of transforming growth factor-β receptor type II gene in sporadic gastric cancer. Cancer J 10: 211-216
41. Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC (1998) Expression of p161NK/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene 17: 2779-2785
42. Yokozaki H (2000) Molecular charachteristics of eight gastric cancer cell lines established in Japan. Pathol Int, 50: 767-777
43. Yokozaki H, Yasui W, Tahara E (2001) Genetic and epigenetic changes in stomach cancer. Int Rev Cytol 204: 49-95